eISSN: 2353-9461
ISSN: 0860-7796
BioTechnologia
Current issue Archive About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
3/2011
vol. 92
 
Share:
Share:
abstract:

REVIEW PAPER
Virtual screening strategies in drug design – methods and applications

Ewa Bielska
,
Xavier Lucas
,
Anna Czerwoniec
,
Joanna M. Kasprzak
,
Katarzyna H. Kaminska
,
Janusz M. Bujnicki

BioTechnologia vol. 92(3) C pp. 249-264 C 2011
Online publish date: 2014/10/28
View full text Get citation
 
PlumX metrics:
Virtual screening (VS) overcomes the limitations of traditional high-throughput screening (HTS) by applying computer-

based methods in drug discovery. VS takes advantage of fast algorithms to filter chemical space and successfully

select potential drug candidates. A key aspect in structure-based VS is the sampling of ligand-receptor conformations

and the evaluation of these poses to predict near-native binding modes. The development of fast and

accurate algorithms during the last few years has allowed VS to become an important tool in drug discovery and

design. Herein, an overview of widely used ligand-based (e.g., similarity, pharmacophore searches) and structurebased

(protein-ligand docking) VS methods is discussed. Their strengths and limitations are described, along with

many successful stories. This review not only serves as an introductory guide for inexperienced VS users but also

presents a general overview of the current state and scope of these powerful tools.
keywords:

high-throughput virtual screening, drug design, drug discovery, ligand-based, similarity searches, pharmacophore, receptor-based, protein-ligand docking

 
Stosujemy się do standardu HONcode dla wiarygodnej informacji zdrowotnej This site complies with the HONcode standard for trustworthy health information: verify here